Article Details

Zynerba Pharmaceuticals (ZYNE) Rating Lowered to Sell at ValuEngine

Retrieved on: 2019-03-12 11:33:45

Tags for this article:

Click the tags to see associated articles and topics

Zynerba Pharmaceuticals (ZYNE) Rating Lowered to Sell at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new stake in shares of Zynerba Pharmaceuticals during the 4th quarter valued at approximately $120,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo